| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.094 | 0.06 |